drugset
drugset / Trial / NCT04990310

Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants

NCT04990310 ↗

Phase 1 Completed 6 enrolled Corcept Therapeutics
NaSingle-groupOpen-labelBasic science

Summary

This study will evaluate the mass balance recovery and metabolite profile, and will identify metabolite structures following a single oral dose of \[14C\]-CORT113176 in healthy male participants.

Timeline

Start
2021-08-18
Primary completion
2021-09-20
Completion
2021-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dazucorilant Small molecule 450 mg Oral

Indications

No indication recorded.